A detailed history of Dunhill Financial, LLC transactions in Novartis Ag stock. As of the latest transaction made, Dunhill Financial, LLC holds 507 shares of NVS stock, worth $52,494. This represents 0.03% of its overall portfolio holdings.

Number of Shares
507
Previous 507 -0.0%
Holding current value
$52,494
Previous $54 Million 8.04%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$92.57 - $107.37 $833 - $966
9 Added 1.81%
507 $54 Million
Q4 2023

Feb 12, 2024

BUY
$92.27 - $101.54 $45,950 - $50,566
498 New
498 $45.6 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.